Atlas Trials

Study to Assess the Safety, Tolerability, and Effects of CHI-202 to Support Recovery From Physical Activity

Clinical trial NCT05026164 · COMPLETED

Trial details

NCT number
NCT05026164
Sponsor
Canopy Growth Corporation
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Delayed Onset Muscle Soreness (DOMS)
Start date
2021-12-13
Primary completion
2022-02-04
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.